The Ophthalmologist

The Ophthalmologist delivers authentic journalism specifically focused on ophthalmology. We highlight compelling stories by collaborating with leading experts in the field, sharing their insights and perspectives. Our aim is to educate, inform, engage, and entertain doctors, offering valuable insights thanks to our skilled team that truly understands the subject. This dedication is what makes The Ophthalmologist a trusted source for breaking significant and impactful news ahead of others.

Local

English

Magazine

Outlet metrics

Domain Authority

Ranking

Global

#1159639

United States

#771197

Health/Medicine

#4724

Traffic sources

Monthly visitors

Articles

Technological Advances Offset Drop Burden for Cataract Patients and Staff

Jan 26, 2025 | theophthalmologist.com | Eric Mann

New study reveals patient and staff experience with a dexamethasone intracanalicular insert that eliminates steroid dropsEric Mann | | 5 min read | Discussion In my practice, patients have historically been prescribed three separate postoperative medications after cataract surgery: a corticosteroid, a nonsteroidal anti-inflammatory drug (NSAID), and an antibiotic. This regimen of three separate drops can be quite expensive for patients, depending on their formulary and co-pays.
Mentorship, Motherhood, and Molecular Science

Jan 19, 2025 | theophthalmologist.com | Andrea Tooley

Sitting Down With... Andrea Tooley, Associate Professor of Oculoplastic and Orbital Surgery and Ophthalmology Residency Program Director at Mayo Clinic, Rochester, Minnesota, USAAndrea Tooley | | 5 min read | Interview As I was wrapping up my residency I decided to do the American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS) fellowship in New York.
Tackling PCV in Asia

Jan 12, 2025 | theophthalmologist.com | Alun Evans

Stefan Scheidl, VP and Global Head of Ophthalmology Medical Affairs at Roche, discusses the 16-week interim data of the SALWEEN trialAlun Evans | | 4 min read | Interview Roche's ongoing SALWEEN trial is seeking to investigate the efficacy, safety, and durability of Vabysmo for patients in Asia suffering from polypoidal choroidal vasculopathy (PCV). We speak with VP, Global Head of Ophthalmology Medical Affairs at the company, Stefan Scheidl, to learn more about how the trial is progressing.
Arshad M. Khanani

Dec 10, 2024 | theophthalmologist.com | Arshad Khanani

Following the launch of The Ophthalmologist's Retina newsletter this year, we present a round-up of Retina editorials by leaders in the fieldArshad M. Khanani | | Opinion It has been a busy year, full of medical meetings with friends and colleagues from around the globe. One thing is for certain, the future has never looked brighter for our field.
The Ophthalmologist Power List 2025: Nominate Now!

Nov 18, 2024 | theophthalmologist.com | Julian Upton

The Power List celebrates the world's most inspiring and influential ophthalmologistsJulian Upton | | 3 min read | News The Ophthalmologist Power List returns in 2025 for its 12th iteration, once again celebrating the top minds and personalities in the field. And they must be nominated by you - the eye care community.
Demystifying Retina Neuroprotection

Nov 17, 2024 | theophthalmologist.com | Allen Ho

We've experienced a sea change over the last few decades in our ability to treat chronic retinal diseases such as age-related macular degeneration (AMD) and diabetic retinopathy (DR). Although we may not always think of it explicitly, neuroprotection is central to these treatment efforts, as the retina is, of course, a neural tissue.
When the socket shrinks, you have to think

Nov 12, 2024 | theophthalmologist.com | Richard Allen

Creating the best surgical outcomes for patients suffering from segmental or global anophthalmic socket contractionRichard C. Allen | | 6 min read | Practical Patients who have an anophthalmic socket can have a variety of issues to contend with. It is important to remember that they have lost one of their vital organs, leaving them with monocular vision and depth perception difficulties.
Gene Detectives

Aug 29, 2024 | theophthalmologist.com | Alun Evans

How early genetic testing for inherited retinal diseases (IRDs) can empower patients to take proactive control of their eye healthAlun Evans | | 8 min readsponsored by Johnson & JohnsonJanssen Pharmaceutica NV, a Johnson & Johnson company, has funded the development and publication of this article, including a consultancy fee for Professor Bolz and Dr. Herrmann.
My Choice of Glaucoma Drainage Device

Aug 29, 2024 | theophthalmologist.com | Julian Upton

Why Wills Eye Hospital surgeon, Michael Pro, opts for the Ahmed ClearPath ® to treat patients with advanced glaucomaJulian Upton | | 6 min read | Opinionsponsored by New World Medical Michael Pro, MD, a board-certified ophthalmologist and attending physician specializing in glaucoma at Wills Eye Hospital, Philadelphia USA, adopted the Ahmed ClearPath (ACP) - a novel valveless glaucoma drainage device (GDD) - shortly after its launch in 2019.
Unraveling Glaucoma's Genetic Tapestry

Aug 25, 2024 | theophthalmologist.com | David Mackey

Key questions for a new era of precision medicine in glaucomaDavid Mackey | | 4 min read | OpinionGlaucoma has long been recognized as a disease underpinned by a complex interplay of genetic and environmental factors.